Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Policy + Initiatives

    Congress Passes Pandemic All-Hazard Preparedness Act

    By Global Biodefense StaffJanuary 22, 2013
    Share
    Facebook LinkedIn Reddit Email

    The U.S. House of Representatives today approved the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013, H.R. 307. The legislation, introduced by Rep. Mike Rogers (R-MI), reauthorizes provisions of the Project Bioshield Act of 2004 and Pandemic and All-Hazards Preparedness Act (PAHPA) of 2006 for an additional five years.

    H.R. 307 continues to strengthen the nation’s preparedness infrastructure and support development of medical countermeasures to better respond to chemical, biological, radiological, and nuclear attacks.

    The bill was brought to vote under a suspension of House rules, a common practice for bills expected to easily obtain at least a two-thirds majority, allowing just 40 minutes of debate prior to a vote. 

    Energy and Commerce Committee Chairman Fred Upton (R-MI) said, “I would like to thank Rep. Rogers along with all the other members who worked on this bipartisan bill that will improve the nation’s health infrastructure to help us respond to a terrorist attack and provide additional flexibility for emergency distribution, stockpiling and use of medical countermeasures to ensure the nation is prepared for public health emergencies. As the nation grapples with a severe flu season, the need to pass this legislation is ever more apparent.”

    The vote passed by an overwhelming 91 percent majority. Voting against H.R. 307 were 29 House Republicans. No House Democrats voted against the bill.

    The full text of H.R. 307 is available here.

    Emerging Threats Pandemic
    Share. Facebook LinkedIn Reddit Email
    Previous ArticlePandemic Lessons from the Koala Retrovirus
    Next Article Tetravalent Dengue Vaccine Candidate Shows Promise in Early Trials

    Related Stories

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    The Basics on the Nipah Virus Outbreak in India

    September 19, 2023

    Healthcare Workers Express Outrage at Flawed CDC Mask Guidance

    September 18, 2023

    Bird Flu Undergoing Changes That Could Increase Risk of Widespread Human Transmission

    September 14, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy